Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of FWD1802 in Healthy Chinese Subjects
NCT07476963Phase 1Active, not recruiting
- Start
- Mar 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fwd1802 (3 arms). Primary endpoints: Peak Plasma Concentration at 240 hours, Area under the plasma concentration versus time curve from time 0 to time t at 240 hours and 1 more. Started Mar 2026; status: active, not recruiting.
02
Drugs
fwd1802
Beyond the preview
Go deeper on NCT07476963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07476963.